Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel room temperature synthesis method for cycloalkyl aminoacetonitrile derivatives. High yield, mild conditions, suitable for industrial scale-up and cost reduction.
Novel carbonyl reductase mutant enables high-purity chiral intermediate synthesis with reduced solvent waste and cost for pharmaceutical supply chains.
Patent CN105153158A details high-yield synthesis of nitrogen-containing heterocyclic fused derivatives offering significant supply chain and cost advantages for pharmaceutical manufacturing.
Novel CO2 fixation method for 4 5 dimethyl 1 3 dioxole 2 ketone offers safer greener pharmaceutical intermediate manufacturing with high purity and scalability.
Explore patented chromone synthesis for oncology. Reliable supplier offering cost-effective scale-up and high-purity antitumor intermediates for global pharma.
Patent CN102596879B details a high-yield Suzuki coupling route for CHF 5074, offering cost-effective manufacturing and scalable supply for Alzheimer's drug intermediates.
Patent CN119823959B reveals novel imine reductase mutants for high-purity chiral amine synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel patent CN106632015A offers a safer, cheaper Roflumilast synthesis route avoiding noble metals and toxic gases for reliable pharmaceutical intermediates supply.
Patent CN112898318A enables high-purity chiral polycyclic synthesis. Reduces heavy metal risks and improves supply chain reliability for pharma intermediates.
Patent CN112852894A reveals SpAmDH mutant for high-purity chiral amino alcohol. Enables cost reduction and scalable supply chain for pharmaceutical intermediates.
Patent CN1087350C reveals a breakthrough enzymatic method for beta-lactam antibiotics, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN105441401A reveals enzymatic route for HCV intermediates. Reduces heavy metal use and simplifies scale-up for reliable supply.
Patent CN113248370B reveals a catalytic method for sodium o-tolyloxy acetate, offering high purity and reduced energy for agrochemical supply chains.
Patent CN115805096A details a green catalytic route for Vitamin K3. Discover cost reduction in vitamin K3 manufacturing and high-purity menadione supply chain advantages.
Patent CN113234030A details an efficient bromination route for antiviral intermediates. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN110746448A introduces a novel chiral 1,2-ethylenediamine boron-nitrogen ligand. This technology enables cost reduction in asymmetric catalysis manufacturing and ensures high-purity pharmaceutical intermediates.
Patent CN119306599A details a high-yield asymmetric hydrogenation route for Vaborbactam intermediates, offering significant cost reduction and supply chain reliability for global pharma manufacturers.
Patent CN108300744B reveals enzymatic synthesis for high-purity D-heterocyclic amino acids. Discover cost-effective supply chain solutions and scalable manufacturing.
Patent CN103224963A reveals a marine strain method for high-purity chiral amines. Discover cost reduction in pharmaceutical intermediates manufacturing and scalable biocatalysis.
Novel one-pot aldol-hydrogenation route for delta-dodecalactone improves yield by 3-4% and reduces energy consumption for industrial flavor manufacturing.